United States Human Insulin Sales Market Report 2021


Report ID : RNR-8958 Category : Biotechnology Published Date : Aug-2016
Publisher : QYResearch Pages : 103 Format : PDF
This report studies sales (consumption) of Human Insulin in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering
Novo Nordisk
Sanofi
Eli Lilly
Bioton
Dongbao
Gan & Lee
TUL
...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Fast-acting insulin
Intermediate-acting insulin
Long-acting insulin
Split by applications, this report focuses on sales, market share and growth rate of Human Insulin in each application, can be divided into
Application 1
Application 2
Application 3
Table of Contents

1 Human Insulin Overview
1.1 Product Overview and Scope of Human Insulin
1.2 Classification of Human Insulin
1.2.11 Fast-acting insulin
1.2.12 Intermediate-acting insulin
1.2.13 Long-acting insulin
1.3 Applications of Human Insulin
1.4 USA Market Size (Value and Volume) of Human Insulin (2011-2021)
1.4.1 USA Human Insulin Sales, Revenue and Price (2011-2021)
1.4.2 USA Human Insulin Sales and Growth Rate (2011-2021)
1.4.3 USA Human Insulin Revenue and Growth Rate (2011-2021)

2 USA Human Insulin Competition by Manufacturers
2.1 USA Human Insulin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Human Insulin Revenue and Share by Manufactures (2015-2016)

3 USA Human Insulin (Volume and Value) by Type
3.1 USA Human Insulin Sales and Market Share by Type (2011-2021)
3.2 USA Human Insulin Revenue and Market Share by Type (2011 and 2021)

4 USA Human Insulin (Volume) by Application

5 USA Human Insulin Manufacturers Analysis
5.1 Novo Nordisk
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Human Insulin Product Type and Technology
5.1.2.1 Fast-acting insulin
5.1.2.2 Intermediate-acting insulin
5.1.3 Human Insulin Sales, Revenue, Price of Novo Nordisk (2015 and 2016)
5.2 Sanofi
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Medicine Product Type and Technology
5.2.2.1 Fast-acting insulin
5.2.2.2 Intermediate-acting insulin
5.2.3 Medicine Sales, Revenue, Price of Sanofi (2015 and 2016)
5.3 Eli Lilly
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Eli Lilly Product Type and Technology
5.3.2.1 Fast-acting insulin
5.3.2.2 Intermediate-acting insulin
5.3.3 Eli Lilly Sales, Revenue, Price of Eli Lilly (2015 and 2016)
5.4 Bioton
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Product Type and Technology
5.4.2.1 Fast-acting insulin
5.4.2.2 Intermediate-acting insulin
5.4.3 Bioton Sales, Revenue, Price of Bioton (2015 and 2016)
5.5 Dongbao
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Dongbao Product Type and Technology
5.5.2.1 Fast-acting insulin
5.5.2.2 Intermediate-acting insulin
5.5.3 Dongbao Sales, Revenue, Price of Dongbao (2015 and 2016)
5.6 Gan & Lee
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Gan & Lee Product Type and Technology
5.6.2.1 Fast-acting insulin
5.6.2.2 Intermediate-acting insulin
5.6.3 Gan & Lee Sales, Revenue, Price of Gan & Lee (2015 and 2016)
5.7 TUL
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 TUL Product Type and Technology
5.7.2.1 Fast-acting insulin
5.7.2.2 Intermediate-acting insulin
5.7.3 TUL Sales, Revenue, Price of TUL (2015 and 2016)
...

6 Human Insulin Technology and Development Trend
6.1 Human Insulin Technology Analysis
6.2 Human Insulin Technology Development Trend

7 Research Findings and Conclusion